gains

phototechno Abeona Therapeutics (NASDAQ:ABEO) traded higher on Thursday after the company announced a partnership with eye care drug developer Beacon to evaluate its patented technology, AAV204, for gene therapies. Per the terms, Beacon, which belongs to Syncona’s clinical portfolio of companies, will have a non-exclusive right to evaluate AAV204 capsidContinue Reading

designer491/iStock via Getty Images STAAR Surgical (NASDAQ:STAA) rose 6.5% amid some takeover speculation. The maker of implantable lenses is said to have been approached by larger rival Alcon (ALC), according to a StreetInsider report on Wednesday, which cited an unidentified source. It’s not clear if the approach will lead toContinue Reading

Apple (NASDAQ:AAPL) rose over 1% and was on track for a seventh straight session of gain, as the tech giant reportedly aims to ship at least 90M iPhone 16 devices in the latter half of this year. The stock was trading at $231.26 on Wednesday afternoon, after spiking 1.6% toContinue Reading

Qualcomm (NASDAQ:QCOM) shares snapped six straight sessions of gains, as the stock closed 0.4% lower at $207.1 on Tuesday. The San Diego-based semiconductor maker gained over 4% in the preceding six sessions. The stock has lost more than 40% so far this year, compared to the nearly 17% rise inContinue Reading

Maksim Labkouski Shares of ReShape Lifesciences (NASDAQ:RSLS) climbed in the premarket Tuesday after the medical device maker reached a merger agreement to combine with privately held specialty pharma company Vyome Therapeutics in an all-stock transaction. Per the terms of the deal, current ReShape (RSLS) stockholders will own a roughly 11.1%Continue Reading

Artur Plawgo uniQure (NASDAQ:QURE) shares traded higher premarket Tuesday after the Dutch biotech posted the latest data from its Phase 1/2 clinical trials for AMT-130, an investigational gene therapy for Huntington’s disease, a rare, inherited neurodegenerative disorder. Based on a Mar. 31 data cut of 21 patients, the company saidContinue Reading